03/05/2021
3:43 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2021
3:38 PM | VistaGen Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/02/2021
4:17 PM | VistaGen Therapeutics (Issuer)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2021
4:13 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2021
4:26 PM | Rosalind Advisors, Inc. (Filed by)
VistaGen Therapeutics (Subject)
| Form SC 13G/A
| |
01/06/2021
3:05 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2021
3:48 PM | SNODGRASS H. RALPH (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2021
3:47 PM | GIN JERRY B (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2021
5:00 AM | Growth Equity Opportunities 17, LLC (Filed by)
VistaGen Therapeutics (Subject)
| Form SC 13D
| |
12/31/2020
4:21 PM | VistaGen Therapeutics (Filer)
| Form PRE 14A
| |
|
12/22/2020
3:17 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2020
5:38 AM | VistaGen Therapeutics (Subject)
| Form FWP
| |
12/17/2020
4:13 PM | VistaGen Therapeutics (Filer)
| Form 424B5
| |
11/12/2020
3:36 PM | VistaGen Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/18/2020
3:56 PM | Rosalind Advisors, Inc. (Filed by)
VistaGen Therapeutics (Subject)
| Form SC 13G
| |
09/18/2020
8:14 AM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2020
3:31 PM | SAXE JON S (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2020
4:24 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2020
3:26 PM | VistaGen Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2020
8:56 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2020
7:45 PM | VistaGen Therapeutics (Filer)
| Form 424B5
| |
07/27/2020
3:52 PM | VistaGen Therapeutics (Filer)
| Form DEFA14A
| |
07/27/2020
3:51 PM | VistaGen Therapeutics (Filer)
| Form DEF 14A
| |
07/24/2020
5:03 AM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2020
4:35 PM | SNODGRASS H. RALPH (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2020
4:33 PM | Smith Mark Alan (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2020
4:28 PM | DOTSON JERROLD DUANE (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2020
4:20 PM | Singh Shawn (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2020
3:16 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2020
4:27 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/18/2020
4:15 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2020
11:15 PM | VistaGen Therapeutics (Filer)
| Form EFFECT
| |
04/14/2020
11:15 PM | VistaGen Therapeutics (Filer)
| Form EFFECT
| |
04/03/2020
4:15 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2020
4:28 PM | VistaGen Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/26/2020
6:05 AM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2020
3:39 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2020
11:12 AM | SPHERA FUNDS MANAGEMENT LTD. (Filed by)
VistaGen Therapeutics (Subject)
| Form SC 13G/A
| |
01/31/2020
4:25 PM | VistaGen Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/31/2020
4:22 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2020
5:02 AM | Lincoln Park Capital Fund, LLC (Filed by)
VistaGen Therapeutics (Subject)
| Form SC 13G
| |
01/24/2020
4:01 PM | VistaGen Therapeutics (Filer)
| Form 424B5
| |
12/27/2019
3:05 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2019
4:14 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2019
6:52 PM | SNODGRASS H. RALPH (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2019
6:46 AM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2019
4:02 PM | DOTSON JERROLD DUANE (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2019
4:01 PM | MCPARTLAND MARK A. (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2019
4:01 PM | Smith Mark Alan (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2019
4:01 PM | SNODGRASS H. RALPH (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2019
4:01 PM | Singh Shawn (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2019
4:01 PM | Cunningham Ann Michelle (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2019
4:00 PM | Underdown Brian J. (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2019
4:00 PM | GIN JERRY B (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2019
4:00 PM | SAXE JON S (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2019
11:15 PM | VistaGen Therapeutics (Filer)
| Form EFFECT
| |
09/30/2019
9:44 PM | VistaGen Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/30/2019
4:31 PM | VistaGen Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/25/2019
3:03 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2019
3:55 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2019
3:37 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2019
3:06 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2019
3:11 PM | VistaGen Therapeutics (Filer)
| Form DEFA14A
| |
07/25/2019
3:08 PM | VistaGen Therapeutics (Filer)
| Form DEFA14A
| |
07/23/2019
4:12 PM | VistaGen Therapeutics (Filer)
| Form DEF 14A
| |
07/23/2019
3:31 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2019
4:20 PM | VistaGen Therapeutics (Filer)
| Form PRE 14A
| |
06/25/2019
3:17 PM | VistaGen Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
06/21/2019
4:00 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2019
3:20 PM | SAXE JON S (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2019
3:18 PM | GIN JERRY B (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2019
3:17 PM | Underdown Brian J. (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2019
3:12 PM | Smith Mark Alan (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2019
3:10 PM | MCPARTLAND MARK A. (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2019
3:09 PM | DOTSON JERROLD DUANE (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2019
3:07 PM | Singh Shawn (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2019
4:22 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2019
3:10 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2019
4:22 PM | SAXE JON S (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2019
4:12 PM | SNODGRASS H. RALPH (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2019
3:50 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2019
3:15 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2019
3:36 PM | VistaGen Therapeutics (Filer)
| Form 424B5
| |
02/25/2019
3:40 PM | VistaGen Therapeutics (Filer)
| Form 424B5
| |
02/12/2019
3:34 PM | VistaGen Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/08/2019
1:01 PM | INTRACOASTAL CAPITAL, LLC (Filed by)
VistaGen Therapeutics (Subject)
| Form SC 13G/A
| |
01/30/2019
3:05 PM | SAXE JON S (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2019
3:29 PM | Singh Shawn (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2019
3:16 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2019
8:55 PM | Singh Shawn (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2019
8:55 PM | Cunningham Ann Michelle (Reporting)
VistaGen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2019
8:50 PM | Cunningham Ann Michelle (Reporting)
VistaGen Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/11/2019
4:30 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2019
12:58 PM | SABBY MANAGEMENT, LLC (Filed by)
VistaGen Therapeutics (Subject)
| Form SC 13G/A
| |
12/17/2018
9:25 AM | VistaGen Therapeutics (Filer)
| Form CT ORDER
| |
12/13/2018
4:00 PM | VistaGen Therapeutics (Filer)
| Form 8-K/A
| |
10/30/2018
3:37 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2018
3:30 PM | VistaGen Therapeutics (Filer)
| Form 10-Q/A
| |
10/29/2018
3:16 PM | VistaGen Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/26/2018
3:21 PM | VistaGen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
